Sonam Sinha

Sonam Sinha

Auto-generated profile, based on publicly available information

Sonam Sinha

A Department of Pharmacognosy and Phytochemistry , B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre , Ahmedabad , Gujarat , India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
Sajid KhanSajid Khan
Sajid Khan
SSSamriddhi Shukla
Samriddhi Shukla
SSSonam Sinha
Sonam Sinha
SMSyed Musthapa Meeran
Syed Musthapa Meeran

24 February 2016 in Scientific Reports
Verified
Journal Article
Open access
SSSamriddhi Shukla
Samriddhi Shukla
SSSonam Sinha
Sonam Sinha
Sajid KhanSajid Khan
Sajid Khan
SKSudhir Kumar
Sudhir Kumar
KSKavita Singh
Kavita Singh
SMSyed Musthapa Meeran
Syed Musthapa Meeran
Lack of effective anti-metastatic drugs creates a major hurdle for metastatic lung cancer therapy. For successful lung cancer treatment, there is a strong need of newer therapeutics with metastasis-inhibitory potential. In the present study, we determined the anti-metastatic and anti-angiogenic potential of a natural plant triterpenoid, Cucurbitacin B (CuB) against non-small cell lung cancer (NSCLC) bothin vitroandin vivo. CuB demonstrated a strong anti-migratory and anti-invasive ability against metastatic NSCLC at nanomolar concentrations. CuB also showed significant tumor angiogenesis-inhibitory effects as evidenced by the inhibition of migratory, invasive and tube-forming capacities of human umbilical vein endothelial cells. CuB-mediated inhibition of angiogenesis was validated by the inhibition of pre-existing vasculature in chick embryo chorio-allantoic membrane and matrigel plugs. Similarly, CuB inhibited the migratory behavior of TGF-β1-induced experimental EMT model. The CuB-mediated inhibition of metastasis and angiogenesis was attributable to the downregulation of Wnt/β-catenin signaling axis, validated by siRNA-knockdown ofWnt3andWnt3a. The CuB-mediated downregulation of Wnt/β-catenin signaling was also validated using 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis modelin vivo. Collectively, our findings suggest that CuB inhibited the metastatic abilities of NSCLC through the inhibition of Wnt/β-catenin signaling axis.

1 August 2016 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
SSSonam Sinha
Sonam Sinha
Sajid KhanSajid Khan
Sajid Khan
SSSamriddhi Shukla
Samriddhi Shukla
ALAmar Deep Lakra
Amar Deep Lakra
SKSudhir Kumar
Sudhir Kumar
SMSyed Musthapa Meeran
Syed Musthapa Meeran

6 May 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
JVJaykant Vora
Jaykant Vora
SPShivani Patel
Shivani Patel
Mohd AtharMohd Athar
Mohd Athar
SSSonam Sinha
Sonam Sinha
MCMahesh T. Chhabria
Mahesh T. Chhabria
NSNeeta Shrivastava
Neeta Shrivastava
Dengue is a fast spreading mosquito borne viral disease that poses a serious threat to human health. Lack of therapeutic drugs and vaccines signify that more resources need to be explored. Accumulated evidence has suggested that plants offer a vast reservoir for anti-viral drug discovery which are safe for human consumption. Plant-based drug discovery is a complex and time consuming process as plants possess rich repository of chemically diverse compounds. Various in silico method can make this process simple and economic. We, therefore, performed pharmacophore mapping, molecular docking, molecular dynamics (MD) simulations and ADME prediction in order to screen potential candidates against Dengue. In particular, combined pharmacophore mapping and molecular docking were used to prioritize the potentially active ligands from a ligand library. Biological activities of plant based ligands were predicted using 3D-QSAR pharmacophore modelling. Interaction between proteins namely Envelope G Protein, NS2B/NS3 Protease, NS5 Methyltransferase, NS1, NS5 Polymerase and active plant based ligands (pIC50 > 5.1) were analysed using molecular docking. Best docked complex namely Envelope G protein-Mulberroside C, NS2B-NS3 protease – Curcumin, NS5 Methyltransferase- Chebulic acid, NS1- Mulberroside A, NS5 Methyltransferase - Punigluconin and NS5 Methyltransferase - Chebulic acid were further subjected to molecular dynamics simulations study to assess the fluctuation and conformational changes during protein-ligand interaction. ADME studies were performed to assess their drug-likeness properties. Collectively, these in silico results helped to identify the potential plant based hits against the various receptors of dengue virus which can be further validated by bioactivity based experiments.

31 May 2015 in Cancer Prevention Research
Verified
Journal Article
Open access
PDF file
SSSamriddhi Shukla
Samriddhi Shukla
Sajid KhanSajid Khan
Sajid Khan
SKSudhir Kumar
Sudhir Kumar
SSSonam Sinha
Sonam Sinha
Mohd FarhanMohd Farhan
Mohd Farhan
SMSyed Musthapa Meeran
Syed Musthapa Meeran
Non–small cell lung cancer (NSCLC) represents almost 85% of total diagnosed lung cancer. Studies have shown that combination of DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors is effective against various cancers, including lung cancer. However, optimizing the synergistic dose regime is very difficult and involves adverse side effects. Therefore, in this study, we have shown that cucurbitacin B (CuB), a single bioactive triterpenoid compound, inhibits both DNMTs and HDACs starting at a very low dose of 60 nmol/L in NSCLC H1299 cells. The CuB-mediated inhibition of DNMTs and HDACs in H1299 cells leads to the reactivation of key tumor suppressor genes (TSG) such as CDKN1A and CDKN2A, as well as downregulation of oncogenes c-MYC and K-RAS and key tumor promoter gene (TPG), human telomerase reverse transcriptase (hTERT). The upregulation of TSGs and downregulation of TPG were consistently correlated with the alterations in their promoter methylation and histone modifications. This altered expression of TPG and TSGs is, at least in part, responsible for the inhibition of cellular proliferation and induction of cellular apoptosis in NSCLC. Furthermore, CuB treatment significantly inhibited the tumor incidence and multiplicity in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice, which was associated with the induction of apoptosis and inhibition of hyperproliferation in the lung tissues. Together, our study provides new insight into the CuB-mediated epigenetic alterations and its chemotherapeutic effects on lung cancer. Cancer Prev Res; 8(6); 552–62. ©2015 AACR.

2 January 2018 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
JVJaykant Vora
Jaykant Vora
SPShivani Patel
Shivani Patel
SSSonam Sinha
Sonam Sinha
SSSonal Sharma
Sonal Sharma
ASAnshu Srivastava
Anshu Srivastava
NSNeeta Shrivastava
Neeta Shrivastava
AIDS is one of the multifaceted diseases and this underlying complexity hampers its complete cure. The toxicity of existing drugs and emergence of multidrug-resistant virus makes the treatment worse. Development of effective, safe and low-cost anti-HIV drugs is among the top global priority. Exploration of natural resources may give ray of hope to develop new anti-HIV leads. Among the various therapeutic targets for HIV treatment, reverse transcriptase, protease, integrase, GP120, and ribonuclease are the prime focus. In the present study, we predicted potential plant-derived natural molecules for HIV treatment using computational approach, i.e. molecular docking, quantitative structure activity relationship (QSAR), and ADMET studies. Receptor-ligand binding studies were performed using three different software for precise prediction – Discovery studio 4.0, Schrodinger and Molegrow virtual docker. Docking scores revealed that Mulberrosides, Anolignans, Curcumin and Chebulic acid are promising candidates that bind with multi targets of HIV, while Neo-andrographolide, Nimbolide and Punigluconin were target-specific candidates. Subsequently, QSAR was performed using biologically proved compounds which predicted the biological activity of compounds. We identified Anolignans, Curcumin, Mulberrosides, Chebulic acid and Neo-andrographolide as potential natural molecules for HIV treatment from results of molecular docking and 3D-QSAR. In silico ADMET studies showed drug-likeness of these lead molecules. Structure similarities of identified lead molecules were compared with identified marketed drugs by superimposing both the molecules. Using in silico studies, we have identified few best fit molecules of natural origin against identified targets which may give new drugs to combat HIV infection after wet lab validation.